节点文献

甲状腺癌分子标志物及其在临床诊疗中的应用进展

Thyroid carcinoma biomarkers and its application in clinical diagnosis and treatment:recent progress

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 滕伟强王秋阳马毅张才云郑宏良朱乘婧刘济生

【Author】 TENG Weiqiang;WANG Qiuyang;MA Yi;ZHANG Caiyun;ZHENG Hongliang;ZHU Chengjing;LIU Jisheng;Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University (Second Military Medical University);Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Soochow University;

【通讯作者】 刘济生;

【机构】 海军军医大学(第二军医大学)第一附属医院耳鼻咽喉头颈外科苏州大学第一附属医院耳鼻咽喉头颈外科

【摘要】 甲状腺癌发病与环境因素密切相关,环境变化导致的基因突变和腺体组织分子生物学改变是诱发甲状腺癌的重要因素之一。尽管甲状腺癌的相关分子机制仍未完全阐明,但随着分子生物学技术的发展,越来越多的甲状腺癌特定遗传改变和分子标志物被挖掘出来。本文就甲状腺癌的病因、特异性分子标志物、诊断及靶向治疗研究进展进行综述,为甲状腺癌的临床诊疗提供理论支持。

【Abstract】 Thyroid carcinoma is closely related to environmental factors. Gene mutations and molecular biological changes of gland tissue caused by environmental changes are important factors inducing thyroid carcinoma. Although the molecular mechanism of thyroid carcinoma has not been fully elucidated, increasingly specific genetic changes and molecular markers for thyroid carcinoma have been discovered with the development of molecular biology techniques. This article reviews the recent progresses on the etiology, specific molecular markers, diagnosis and targeted therapies of thyroid carcinoma, so as to provide theoretical support for the clinical diagnosis and treatment of thyroid carcinoma.

【基金】 国家自然科学基金(81970868,81972537,81200734)~~
  • 【文献出处】 海军军医大学学报 ,Academic Journal of Naval Medical University , 编辑部邮箱 ,2024年09期
  • 【分类号】R736.1
  • 【下载频次】197
节点文献中: 

本文链接的文献网络图示:

本文的引文网络